Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; Microbiology and Infectious Diseases Department, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Chieh-Hsi Wu
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom
N Claire Gordon
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom
Kevin Cole
Department of Infectious Diseases and Microbiology, Royal Sussex County Hospital, Brighton, United Kingdom
James R Price
Department of Infectious Diseases and Microbiology, Royal Sussex County Hospital, Brighton, United Kingdom; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom
Elian Liu
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; Microbiology and Infectious Diseases Department, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Anna E Sheppard
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; NIHR Health Protection Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom
Sanuki Perera
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; Microbiology and Infectious Diseases Department, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Jane Charlesworth
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom
Tanya Golubchik
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom
Zamin Iqbal
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
Rory Bowden
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
John Paul
National Infection Service, Public Health England, London, United Kingdom; National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, United Kingdom
Derrick W Crook
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; National Infection Service, Public Health England, London, United Kingdom; National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, United Kingdom
Timothy E Peto
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, United Kingdom
A Sarah Walker
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, United Kingdom
Martin J Llewelyn
Department of Infectious Diseases and Microbiology, Royal Sussex County Hospital, Brighton, United Kingdom; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom
David H Wyllie
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; Centre for Molecular and Cellular Physiology, Jenner Institute, Oxford, United Kingdom
Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Institute for Emerging Infections, Oxford Martin School, University of Oxford, Oxford, United Kingdom
Bacteria responsible for the greatest global mortality colonize the human microbiota far more frequently than they cause severe infections. Whether mutation and selection among commensal bacteria are associated with infection is unknown. We investigated de novo mutation in 1163 Staphylococcus aureus genomes from 105 infected patients with nose colonization. We report that 72% of infections emerged from the nose, with infecting and nose-colonizing bacteria showing parallel adaptive differences. We found 2.8-to-3.6-fold adaptive enrichments of protein-altering variants in genes responding to rsp, which regulates surface antigens and toxin production; agr, which regulates quorum-sensing, toxin production and abscess formation; and host-derived antimicrobial peptides. Adaptive mutations in pathogenesis-associated genes were 3.1-fold enriched in infecting but not nose-colonizing bacteria. None of these signatures were observed in healthy carriers nor at the species-level, suggesting infection-associated, short-term, within-host selection pressures. Our results show that signatures of spontaneous adaptive evolution are specifically associated with infection, raising new possibilities for diagnosis and treatment.